Local pharmaceutical production as means to improve access to essential medicines in developing countries

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In many developing countries, there is lack of essential medicines for main diseases that affect the population. The countries generally do not have the capacities to manufacture their own drugs, and usually depend on medicines developed and produced in wealthy countries to meet local needs. Multinational pharmaceutical companies are reluctant to produce drugs solely for the developing country diseases because of the low purchasing power. Weak infrastructure for industry and technology, shortage of researchers and limited financial resources are among the reasons for lack of adequate pharmaceutical production in poor countries. There are global initiatives to increase accessibility to medicines for some neglected diseases and the international community is encouraging local production of pharmaceuticals as a possible means to make medicines available in developing countries. Nonetheless, some developing countries are able to produce pharmaceuticals locally, primarily generics that cover some percentage of local drug need, while few others are able to produce and export finished products and active pharmaceutical ingredients (APIs) mainly to other developing nations. The article explored issues of access to quality medicines and local production of pharmaceuticals in developing countries and the factors influencing this industry.

Original languageEnglish
Pages (from-to)233-240
Number of pages8
JournalInternational Journal of Pharmacy and Pharmaceutical Sciences
Volume4
Issue numberSUPPL. 4
Publication statusPublished - Sep 2012
Externally publishedYes

Fingerprint

Developing Countries
Pharmaceutical Preparations
Industry
Neglected Diseases
Research Personnel
Technology
Population

Keywords

  • Developing countries
  • Essential medicines
  • India
  • Pharmaceutical production
  • TRIPS

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology

Cite this

@article{edbc4665c5b14c14b81c76568c0502f3,
title = "Local pharmaceutical production as means to improve access to essential medicines in developing countries",
abstract = "In many developing countries, there is lack of essential medicines for main diseases that affect the population. The countries generally do not have the capacities to manufacture their own drugs, and usually depend on medicines developed and produced in wealthy countries to meet local needs. Multinational pharmaceutical companies are reluctant to produce drugs solely for the developing country diseases because of the low purchasing power. Weak infrastructure for industry and technology, shortage of researchers and limited financial resources are among the reasons for lack of adequate pharmaceutical production in poor countries. There are global initiatives to increase accessibility to medicines for some neglected diseases and the international community is encouraging local production of pharmaceuticals as a possible means to make medicines available in developing countries. Nonetheless, some developing countries are able to produce pharmaceuticals locally, primarily generics that cover some percentage of local drug need, while few others are able to produce and export finished products and active pharmaceutical ingredients (APIs) mainly to other developing nations. The article explored issues of access to quality medicines and local production of pharmaceuticals in developing countries and the factors influencing this industry.",
keywords = "Developing countries, Essential medicines, India, Pharmaceutical production, TRIPS",
author = "Amara, {Ahmed Hassan} and {Syed Junid}, {Syed Mohamed Al-Junid}",
year = "2012",
month = "9",
language = "English",
volume = "4",
pages = "233--240",
journal = "International Journal of Pharmacy and Pharmaceutical Sciences",
issn = "0975-1491",
publisher = "IJPPS",
number = "SUPPL. 4",

}

TY - JOUR

T1 - Local pharmaceutical production as means to improve access to essential medicines in developing countries

AU - Amara, Ahmed Hassan

AU - Syed Junid, Syed Mohamed Al-Junid

PY - 2012/9

Y1 - 2012/9

N2 - In many developing countries, there is lack of essential medicines for main diseases that affect the population. The countries generally do not have the capacities to manufacture their own drugs, and usually depend on medicines developed and produced in wealthy countries to meet local needs. Multinational pharmaceutical companies are reluctant to produce drugs solely for the developing country diseases because of the low purchasing power. Weak infrastructure for industry and technology, shortage of researchers and limited financial resources are among the reasons for lack of adequate pharmaceutical production in poor countries. There are global initiatives to increase accessibility to medicines for some neglected diseases and the international community is encouraging local production of pharmaceuticals as a possible means to make medicines available in developing countries. Nonetheless, some developing countries are able to produce pharmaceuticals locally, primarily generics that cover some percentage of local drug need, while few others are able to produce and export finished products and active pharmaceutical ingredients (APIs) mainly to other developing nations. The article explored issues of access to quality medicines and local production of pharmaceuticals in developing countries and the factors influencing this industry.

AB - In many developing countries, there is lack of essential medicines for main diseases that affect the population. The countries generally do not have the capacities to manufacture their own drugs, and usually depend on medicines developed and produced in wealthy countries to meet local needs. Multinational pharmaceutical companies are reluctant to produce drugs solely for the developing country diseases because of the low purchasing power. Weak infrastructure for industry and technology, shortage of researchers and limited financial resources are among the reasons for lack of adequate pharmaceutical production in poor countries. There are global initiatives to increase accessibility to medicines for some neglected diseases and the international community is encouraging local production of pharmaceuticals as a possible means to make medicines available in developing countries. Nonetheless, some developing countries are able to produce pharmaceuticals locally, primarily generics that cover some percentage of local drug need, while few others are able to produce and export finished products and active pharmaceutical ingredients (APIs) mainly to other developing nations. The article explored issues of access to quality medicines and local production of pharmaceuticals in developing countries and the factors influencing this industry.

KW - Developing countries

KW - Essential medicines

KW - India

KW - Pharmaceutical production

KW - TRIPS

UR - http://www.scopus.com/inward/record.url?scp=84866318183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866318183&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84866318183

VL - 4

SP - 233

EP - 240

JO - International Journal of Pharmacy and Pharmaceutical Sciences

JF - International Journal of Pharmacy and Pharmaceutical Sciences

SN - 0975-1491

IS - SUPPL. 4

ER -